This study examined the neuropsychological correlates and impact on caregiver distress of reduced awareness of mood symptoms in patients with suspected neurodegenerative disease.
Method:
Records from a clinical sample of older adults were examined (N = 940).
Results:
More than one-third of patient and caregiver ratings of mood symptoms did not agree (comparing patient and caregiver self-report measures); 27.9% of patients were unaware of depression (UoD) and 16.6% of patients were unaware of anxiety (UoA). The UoD group exhibited poorer verbal memory and executive abilities and the UoA group exhibited poorer verbal memory than those with preserved awareness. Unawareness was not associated with caregiver distress.
Conclusions:
These findings highlight the importance of capturing informant report in clinical practice with older adults suspected of cognitive impairment. Unawareness of mood symptoms was related to memory dysfunction and—to a lesser extent—to executive abilities and may have implications for addressing patient and caregiver needs for disorders affecting these cognitive systems.
ZhaoQFTanLWangHF, et al.The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–271. doi:10.1016/j.jad.2015.09.069.
2.
RosenHJ. Anosognosia in neurodegenerative disease. Neurocase. 2011;17(3):231–241. doi:10.1080/13554794.2010.522588.
3.
McGlynnSMSchacterDL. Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol. 1989;11(2):143–205.
StussDTAlexanderMP. Executive functions and the frontal lobes: a conceptual review. Psychol Res. 2000;63:289–298.
7.
AmanzioMVaseLLeottaDMiceliRPalermoSGeminianiG. Impaired awareness of deficits in alzheimer’s disease: the role of everyday executive dysfunction. J Int Neuropsychol Soc. 2013;19(1):63–72. doi:10.1017/S1355617712000896.
8.
OttBRLaflecheGWhelihanWMBuongiornoGWAlbertMSFogelBS. Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord. 1996;10(2):68–76.
9.
DukeLMSeltzerBSeltzerJEVasterlingJJ. Cognitive components of deficit awareness in Alzheimer’s disease. Neuropsychology. 2002;16(3):359–369. doi:10.1037/0894-4105.16.3.359.
10.
SouchayCIsingriniMGilR. Alzheimer's disease and feeling-of-knowing in episodic memory. Neuropsychologia. 2002;40:2386–2396.
11.
BiranIChatterjeeA. Depression with anosognosia following a left subcortical stroke. Clin Neurol Neurosurg. 2003;105(2):99–101. doi:10.1016/S0303-8467(02)00113-0.
12.
ZamboniGDrazichEMcCullochE, et al.Neuroanatomy of impaired self-awareness in Alzheimer’s disease and mild cognitive impairment. Cortex. 2013;49(3):668–678. doi:10.1016/j.cortex.2012.04.011.
13.
HarwoodDGSultzerDLWheatleyMV. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13(2):83–88. http://www.ncbi.nlm.nih.gov/pubmed/10780626.
14.
MograbiDCMorrisRG. On the relation among mood, apathy, and anosognosia in Alzheimer’s disease. J Int Neuropsychol Soc. 2014;20(1):2–7. doi:10.1017/S1355617713001276.
15.
ChavoixCInsaustiR. Self-awareness and the medial temporal lobe in neurodegenerative diseases. Neurosci Biobehav Rev. 2017;78:1–12. doi:10.1016/j.neubiorev.2017.04.015.
16.
TondelliMBarbaruloAMVincetiG, et al.Neural correlates of anosognosia in alzheimer’s disease and mild cognitive impairment: a multi-method assessment. Front Behav Neurosci. 2018;12:1–11. doi:10.3389/fnbeh.2018.00100.
17.
SchmitzTWRowleyHAKawaharaTNJohnsonSC. Neural correlates of self-evaluative accuracy after traumatic brain injury. Neuropsychologia. 2006;44(5):762–773. doi:10.1016/j.neuropsychologia.2005.07.012.
18.
MackenzieBKnopmanDSRobinerN. Differences between patient and family assessments of depression in Alzheimer’s disease. Am J Psychiatry. 1989;146(9):1174–1178.
19.
TeriLWagnerAW. Assessment of depression in patients with Alzheimer’s disease: concordance among informants. Psychol Aging. 1991;6(2):280–285. doi:10.1037//0882-7974.6.2.280.
20.
VasterlingJJSeltzerBWatrousWE. Longitudinal assessment of deficit unawareness in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10(3):197–202.
21.
VasterlingJJSeltzerBFossJWVanderbrookV.Unawareness of deficit in Alzheimer’s disease: domain-specific differences and disease correlates. Neuropsychiatry Neuropsychol Behav Neurol. 1995;8(1):26–32.
22.
BanksSWeintraubS. Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer’s disease. Brain Cogn. 2008;67(1):58–68. doi:10.1016/j.bandc.2007.11.004.
23.
RankinKPBaldwinEPace-SavitskyCKramerJHMillerBL. Self awareness and personality change in dementia. J Neurol Neurosurg Psychiatry. 2005;76(5):632–639. doi:10.1136/jnnp.2004.042879.
24.
NearyDSnowdenJSGustafsonL, et al.Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–1554. doi:10.1212/WNL.51.6.1546.
25.
StarksteinSEJorgeRMizrahiRRobinsonRG. A diagnostic formulation for anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2006;77(6):719–725. doi:10.1136/jnnp.2005.085373.
26.
SeltzerBVasterlingJJMathiasCWBrennanA. Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):122–129.
27.
KelleherMToleaMIGalvinJE. Anosognosia increases caregiver burden in mild cognitive impairment. Int J Geriatr Psychiatry. 2016;31(7):799–808. doi:10.1002/gps.4394.
28.
Turrõ-GarrigaOGarre-OlmoJVilalta-FranchJConde-SalaJLDe Gracia BlancoMLõpez-PousaS. Burden associated with the presence of anosognosia in Alzheimer’s disease. Int J Geriatr Psychiatry. 2013;28(3):291–297. doi:10.1002/gps.3824.
29.
KauferDICummingsJLKetchelP, et al.Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239. doi:10.1176/jnp.12.2.233.
30.
RoccaPLeottaDLiffredoC, et al.Neuropsychiatric symptoms underlying caregiver stress and insight in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2010;30(1):57–63. doi:10.1159/000315513.
31.
YesavageJABrinkTLRoseTL, et al.Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. doi:10.1016/0022-3956(82)90033-4.
32.
BeckATEpsteinNBrownGSteerRA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clinc Psychol. 1988;56(6):893–897. doi:10.1037/022-006X.56.6.893.
33.
BeckATSteerRA. Beck Anxiety Inventory Manual. San Antonio, TX: The Psychological Corporation; 1993.
34.
CummingsJL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5suppl 6):10S–16S. doi:10.1212/WNL.48.5_Suppl_6.10 S.
35.
ClareLMarkováIVerheyFKennyG. Awareness in dementia: a review of assessment methods and measures. Aging Ment Health. 2005;9(5):394–413. doi:10.1080/13607860500142903.
36.
Conde-SalaJLTurrõ-GarrigaOPiñán-HernándezS, et al.Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer’s disease: a 24-month follow-up study. Int J Geriatr Psychiatry. 2016;31(2):109–119. doi:10.1002/gps.4298.
37.
JohnsonNBarionARademakerARehkemperGWeintraubS. The Activities of Daily Living Questionnaire: a validation study in patients with dementia. Alzheimer Dis Assoc Disord. 2004;18(4):223–230. doi:00002093-200410000-00012 [pii].
38.
NasreddineZSPhillipsNABédirianV, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x.
39.
DurantJLegerGCBanksSJMillerJB. Relationship between the Activities of Daily Living Questionnaire and the Montreal Cognitive Assessment. Alzheimers Dement (Amst). 2016;4(2016):43–46. doi:10.1016/j.dadm.2016.06.001.
40.
BrandtJBenedictRH. Hopkins Verbal Learning Test -Revised: Professional Manual. Lutz, FL: Psychological Assessment Resources; 2001.
41.
BenedictRH. Brief Visuospatial Memory Test -Revised: Professional Manual. Lutz, FL: Psychological Assessment Resources; 1997.
42.
Bonner-JacksonAMahmoudSMillerJBanksSJ. Verbal and non-verbal memory and hippocampal volumes in a memory clinic population. Alzheimers Res Ther. 2015;7(1):61. doi:10.1186/s13195-015-0147-9.
43.
LezakMDHowiesonDBBiglerEDTranelD. Executive functions. In: Neuropsychological Assessment. 5th ed. New York, NY: Oxford University Press; 2012:666–711.
44.
SuchyY. Executive functioning: overview, assessment, and research issues for non-neuropsychologists. Ann Behav Med. 2009;37(2):106–116. doi:10.1007/s12160-009-9097-4.
45.
DelisDCKaplanEKramerJH. Delis Kaplan Executive Functioning System: Examiners Manual. San Antonio, TX: The Psychological Corporation; 2001.
46.
PaJPossinKLWilsonSM, et al.Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. J Int Neuropsychol Soc. 2010;16(4):640–650. doi:10.1017/S1355617710000408.
47.
PossinKLBrambatiSMRosenHJ, et al.Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease. J Int Neuropsychol Soc. 2009;15(3):354–364. doi:10.1017/S135561770909050X.
48.
WechslerD. Wechsler Adult Intelligence Scale–Fourth Edition (WAIS-IV). San Antonio, TX: The Psychological Corporation; 2008.
49.
TombaughT. Normative data stratified by age and education for two measures of verbal fluency FAS and animal naming. Arch Clin Neuropsychol. 1999;14(2):167–177. doi:10.1016/S0887-6177(97)00095-4.
50.
LagardeJValabrégueRCorvolJC, et al.Why do patients with neurodegenerative frontal syndrome fail to answer: “In what way are an orange and a banana alike?”Brain. 2015;138(2):456–471. doi:10.1093/brain/awu359.
51.
WilkersonGSRobertsonGJ. WRAT 4: Wide Range Achievement Test: Professional Manual. Lutz, FL: Psychological Assessment Resources; 2006.
52.
BergJLDurantJBanksSJMillerJB. Estimates of premorbid ability in a neurodegenerative disease clinic population: comparing the Test of Premorbid Functioning and the Wide Range Achievement Test, 4th edition. Clin Neuropsychol. 2016;30(4):547–557. doi:10.1080/13854046.2016.1186224.
53.
StraussEShermanEMSpreenO. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York, NY: Oxford University Press; 2006.
54.
SPSS Statistics (for Windows) [computer program]. Version 23. Armonk, NY: IBM Corporation; 2015.
55.
SnowALKunikMEMolinariVA, et al.Accuracy of self-reported depression in persons with dementia. J Am Geriatr Soc. 2005;53(3):389–396. doi:10.1111/j.1532-5415.2005.53154.x.
56.
VerhülsdonkSQuackRHöftBLange-AsschenfeldtCSupprianT. Anosognosia and depression in patients with Alzheimer’s dementia. Arch Gerontol Geriatr. 2013;57(3):282–287. doi:10.1016/j.archger.2013.03.012.
57.
van VlietDde VugtMEKohlerS, et al.Awareness and its association with affective symptoms in young-onset and late-onset Alzheimer disease: a prospective study. Alzheimer Dis Assoc Disord. 2013;27(3):265–271. doi:10.1097/WAD.0b013e31826cffa5.
58.
VogelAWaldorffFBWaldemarG. Impaired awareness of deficits and neuropsychiatric symptoms in early Alzheimer’s disease: the Danish Alzheimer Intervention Study (DAISY). J Neuropsychiatry Clin Neurosci. 2010;22(1):93–99. doi:10.1176/appi.neuropsych.22.1.93.
59.
SunderaramanPCosentinoS. Integrating the constructs of anosognosia and metacognition: a review of recent findings in dementia. Curr Neurol Neurosci Rep. 2017;17(3):27. doi:10.1007/s11910-017-0734-1.
60.
StarksteinSE. Anosognosia in Alzheimer’s disease: diagnosis, frequency, mechanism and clinical correlates. Cortex. 2014;61:64–73. doi:10.1016/j.cortex.2014.07.019.
61.
VogelAWaldorffFBWaldemarG. Longitudinal changes in awareness over 36 months in patients with mild Alzheimer’s disease. Int Psychogeriatrics. 2015;27(1):95–102. doi:10.1017/S1041610214001562.
62.
BarrettAMEslingerPJBallentineNHHeilmanKM. Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects. Neurology. 2005;64(4):693–699. doi:10.1212/01.WNL.0000151959.64379.1B.
63.
RymerSSallowaySNortonLMalloyPCorreiaSMonastD. Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002;16(4):248–253. doi:10.1097/00002093-200210000-00006.
64.
SeltzerBVasterlingJJYoderJAThompsonKA. Awareness of deficit in Alzheimer’s disease: relation to caregiver burden. Gerontologist. 1997;37(1):20–24. doi:10.1093/geront/37.1.20.
65.
StarksteinSEPetraccaGChemerinskiEKremerJ. Syndromic validity of apathy in Alzheimer’s disease. Am J Psychiatry. 2001;158(6):872–877. doi:10.1176/appi.ajp.158.6.872.
66.
CacchionePZPowlishtaKKGrantEABucklesVDMorrisJC. Accuracy of collateral source reports in very mild to mild dementia of the alzheimer type. J Am Geriatr Soc. 2003;51(6):819–823. doi:10.1046/j.1365-2389.2003.51263.x.
67.
LogsdonRGTeriL. Depression in Alzheimer’s disease patients: caregivers as surrogate reporters. J Am Geriatr Soceity. 1995:150–155.
68.
HoeJHancockGLivingstonGOrrellM. Quality of life of people with dementia in residential care homes. Br J Psychiatry. 2006;188(5):460–464. doi:10.1192/bjp.bp.104.007658.
69.
TsataliMPapaligkasVDamigosDMavreasVGuovaMTsolakiM. Depression and anxiety levels increase chronic musculoskeletal pain in patients with Alzheimer’s disease. Curr Alzheimer Res. 2014;11(6):574–579.
70.
HynninenMJBreitveMHRongveAAarslandDNordhusIH. The frequency and correlates of anxiety in patients with first-time diagnosed mild dementia. Int Psychogeriatr. 2012;24(11):1771–1778. doi:10.1017/S1041610212001020.
71.
OrtegaVQaziASpectorAOrrellM.Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiatry. 2015;207:293–298.
72.
KoltaiDCWelsh-BohmerKASchmechelDE. Influence of anosognosia on treatment outcome among dementia patients. Neuropsychol Rehabil. 2001;11(3-4):455–475. doi:10.1080/09602010042000097.
73.
DirekNSchrijversEMCde BruijnRFAG, et al.Plasma amyloid β, depression, and dementia in community-dwelling elderly. J Psychiatr Res. 2013;47(4):479–485. doi:10.1016/j.jpsychires.2012.12.008.
74.
TherriaultJNgKPPascoalTA, et al.Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology. 2018;90(11):e932–e939. doi:10.1212/WNL.0000000000005120.
75.
GonyeaJG. Subjective appraisal of Alzheimer’s disease caregiving: the role of self-efficacy and depressive symptoms in the experience of burden. Am J Alzheimers Dis Other Demen. 2005;20(5):273–280. doi:10.1177/153331750502000505.
76.
RinaldiPSpazzafumoLMastrifortiR, et al.Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study. Int J Geriatr Psychiatry. 2005;20(2):168–174. doi:10.1002/gps.1267.
77.
OkuraTPlassmanBLSteffensDCLlewellynDJPotterGGLangaKM. Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011;59(3):473–481.
78.
PeralesJTurró-GarrigaOGascón-BayarriJReñé-RamírezRConde-SalaJL. The longitudinal association between a discrepancy measure of anosognosia in patients with dementia, caregiver burden and depression. J Alzheimer’s Dis. 2016;53(3):1133–1143. doi:10.3233/JAD-160065.
79.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state: a grading the cognitive state of patiens for the clinician. J Psychiatr Res. 1975;12:189–198. doi:10.1016/0022-3956(75)90026-6.
80.
Shany-UrTLinNRosenHJSollbergerMMillerBLRankinKP. Self-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention. Brain. 2014;137(8):2368–2381. doi:10.1093/brain/awu161.
81.
MakEChinRNgLTYeoDHameedS. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry. 2015;30(12):1207–1214. doi:10.1002/gps.4275.
82.
Hartman-MaierASorokerNRingHKatzN. Awareness of deficits in stroke rehabilitation. J Rehabil Med. 2002;34(4):158–164. doi:10.1080/16501970213236.
83.
LogsdonRGGibbonsLEMcCurrySMTeriL. Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging. 1999;5(1):21–32.
84.
Gomez-GallegoMGomez-GarciaJAto-LozanoE. Addressing the bias problem in the assessment of the quality of life of patients with dementia: determinants of the accuracy and precision of the proxy ratings. J Nutr Heal Aging. 2015;19(3):365–372. doi:10.1007/s12603-014-0564-7.
